165 results
Page 5 of 9
CORRESP
d4c6g70n1bac7l8bl0k9
21 Feb 20
Correspondence with SEC
12:00am
CORRESP
fuazg40u
31 Jan 20
Correspondence with SEC
12:00am
8-K
EX-99.1
33k994rej0x9mcmm
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
28vgic4ti2b
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
nztgu9n4
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
CORRESP
pq558vthp540wx5z
13 Dec 19
Correspondence with SEC
12:00am
8-K
EX-99.1
1r2hsy9ju2cr1c0
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
jv6pq8iyowwbvq9
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
owknxx3 utq24r2di
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
g56quvv4 jdoxmr0lwmt
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
aus4 zodef1kbts6t
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
jtka56k6f96q7rk
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
pyloqyov9vq9eea8ap
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
ivqd ntobhul68
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
zpi0np p2
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
wdrwbhpczu0 tb2
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
iade85pp
26 Aug 19
Departure of Directors or Certain Officers
9:04am